100 related articles for article (PubMed ID: 8980970)
21. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH
J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239
[TBL] [Abstract][Full Text] [Related]
22. Trimodality therapy for malignant pleural mesothelioma.
Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Anand A; Anand A; Anand N
Cancer; 1996 May; 77(9):1959-60. PubMed ID: 8646700
[No Abstract] [Full Text] [Related]
24. Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis.
El Hossieny HA; Aboulkasem F; Abdel Rahman M
Zhongguo Fei Ai Za Zhi; 2010 Jan; 13(1):54-9. PubMed ID: 20672705
[TBL] [Abstract][Full Text] [Related]
25. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy.
Ball DL; Cruickshank DG
Am J Clin Oncol; 1990 Feb; 13(1):4-9. PubMed ID: 1689538
[TBL] [Abstract][Full Text] [Related]
26. Topotecan and pegylated liposomal doxorubicin combination as palliative treatment in patients with pretreated advanced malignant pleural mesothelioma.
Trafalis DT; Alifieris C; Krikelis D; Tzogkas N; Stathopoulos GP; Athanassiou AE; Sitaras NM
Int J Clin Pharmacol Ther; 2012 Jul; 50(7):490-9. PubMed ID: 22578202
[TBL] [Abstract][Full Text] [Related]
27. Complete response and long-term survival in malignant pleural mesothelioma: case report.
Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
[TBL] [Abstract][Full Text] [Related]
28. Malignant mesotheliomas and chemotherapy.
Karakousis CP; Seddiq M; Moore R
J Surg Oncol; 1980; 15(2):181-5. PubMed ID: 7421277
[TBL] [Abstract][Full Text] [Related]
29. High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four cases.
Stewart DJ; Gertler SZ; Tomiak A; Shamji F; Goel R; Evans WK
Lung Cancer; 1994 Sep; 11(3-4):251-8. PubMed ID: 7812702
[TBL] [Abstract][Full Text] [Related]
30. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura.
Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J
Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.
Metintas M; Ozdemir N; Uçgun I; Elbek O; Kolsuz M; Mutlu S; Metintas S
Chest; 1999 Aug; 116(2):391-8. PubMed ID: 10453867
[TBL] [Abstract][Full Text] [Related]
32. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
[TBL] [Abstract][Full Text] [Related]
33. Oral cyclophosphamide and etoposide in treatment of malignant pleural mesothelioma.
Gunduz S; Mutlu H; Goksu SS; Arslan D; Tatli AM; Uysal M; Coskun HS; Bozcuk H; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(20):8843-6. PubMed ID: 25374217
[TBL] [Abstract][Full Text] [Related]
34. Surgical treatment of malignant pleural mesothelioma: a review.
van Ruth S; Baas P; Zoetmulder FA
Chest; 2003 Feb; 123(2):551-61. PubMed ID: 12576380
[TBL] [Abstract][Full Text] [Related]
35. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
Kasseyet S; Astoul P; Boutin C
Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568
[TBL] [Abstract][Full Text] [Related]
36. High-dose palliative radiotherapy for malignant pleural mesothelioma.
Foroudi F; Smith JG; Putt F; Wada M
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):797-803. PubMed ID: 28727277
[TBL] [Abstract][Full Text] [Related]
37. Population based epidemiology and prognosis of mesothelioma in Leeds, UK.
Chapman A; Mulrennan S; Ladd B; Muers MF
Thorax; 2008 May; 63(5):435-9. PubMed ID: 18202164
[TBL] [Abstract][Full Text] [Related]
38. Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study.
Ardizzoni A; Rosso R; Salvati F; Fusco V; Cinquegrana A; De Palma M; Serrano J; Pennucci MC; Soresi E; Crippa M
Cancer; 1991 Jun; 67(12):2984-7. PubMed ID: 2044044
[TBL] [Abstract][Full Text] [Related]
39. Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.
Feigen M; Lee ST; Lawford C; Churcher K; Zupan E; Scott AM; Hamilton C
J Med Imaging Radiat Oncol; 2011 Jun; 55(3):320-32. PubMed ID: 21696568
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
